JP2007532548A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532548A5
JP2007532548A5 JP2007507417A JP2007507417A JP2007532548A5 JP 2007532548 A5 JP2007532548 A5 JP 2007532548A5 JP 2007507417 A JP2007507417 A JP 2007507417A JP 2007507417 A JP2007507417 A JP 2007507417A JP 2007532548 A5 JP2007532548 A5 JP 2007532548A5
Authority
JP
Japan
Prior art keywords
polymorph
mammal
pharmaceutical composition
administering
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007507417A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532548A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/011423 external-priority patent/WO2005100314A1/en
Publication of JP2007532548A publication Critical patent/JP2007532548A/ja
Publication of JP2007532548A5 publication Critical patent/JP2007532548A5/ja
Abandoned legal-status Critical Current

Links

JP2007507417A 2004-04-07 2005-04-06 バゼドキシフェンアセテートの結晶質多形体 Abandoned JP2007532548A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56058404P 2004-04-07 2004-04-07
PCT/US2005/011423 WO2005100314A1 (en) 2004-04-07 2005-04-06 Crystalline polymorph of bazedoxifene acetate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008171116A Division JP2009007361A (ja) 2004-04-07 2008-06-30 バゼドキシフェンアセテートの結晶質多形体

Publications (2)

Publication Number Publication Date
JP2007532548A JP2007532548A (ja) 2007-11-15
JP2007532548A5 true JP2007532548A5 (cg-RX-API-DMAC7.html) 2008-08-14

Family

ID=34965585

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007507417A Abandoned JP2007532548A (ja) 2004-04-07 2005-04-06 バゼドキシフェンアセテートの結晶質多形体
JP2008171116A Withdrawn JP2009007361A (ja) 2004-04-07 2008-06-30 バゼドキシフェンアセテートの結晶質多形体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008171116A Withdrawn JP2009007361A (ja) 2004-04-07 2008-06-30 バゼドキシフェンアセテートの結晶質多形体

Country Status (20)

Country Link
US (1) US7683052B2 (cg-RX-API-DMAC7.html)
EP (1) EP1732889A1 (cg-RX-API-DMAC7.html)
JP (2) JP2007532548A (cg-RX-API-DMAC7.html)
KR (1) KR20070004815A (cg-RX-API-DMAC7.html)
CN (1) CN1938271A (cg-RX-API-DMAC7.html)
AR (1) AR048683A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005233114A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0509257A (cg-RX-API-DMAC7.html)
CA (1) CA2561296A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP066910A (cg-RX-API-DMAC7.html)
GT (1) GT200500080A (cg-RX-API-DMAC7.html)
IL (1) IL178101A0 (cg-RX-API-DMAC7.html)
NO (1) NO20065046L (cg-RX-API-DMAC7.html)
PA (1) PA8629201A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060173A1 (cg-RX-API-DMAC7.html)
RU (1) RU2006132352A (cg-RX-API-DMAC7.html)
TW (1) TW200536845A (cg-RX-API-DMAC7.html)
UA (1) UA86055C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005100314A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200608361B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070003623A1 (en) * 2005-06-29 2007-01-04 Wyeth Formulations of conjugated estrogens and bazedoxifene
CN101304731B (zh) * 2005-08-24 2012-06-20 惠氏公司 醋酸苯卓昔芬制剂及其生产方法
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
CZ302358B6 (cs) * 2007-07-25 2011-03-30 Zentiva, A. S. Nové soli bazedoxifenu
EP2252585B1 (en) * 2008-02-11 2013-11-06 Wyeth LLC Methods of preparing polymorphic form a of bazedoxifene acetate
US20100016290A1 (en) * 2008-02-11 2010-01-21 Livius Cotarca Amorphous polymorph of bazedoxifene acetate
ITMI20091109A1 (it) * 2009-06-23 2010-12-24 Wyeth Corp Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
EP2493477B1 (en) 2009-10-27 2013-10-16 Wyeth LLC Bazedoxifene formulations with antioxidants
WO2012007453A1 (en) 2010-07-14 2012-01-19 Sandoz Ag Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol
EP2407467A1 (de) 2010-07-14 2012-01-18 Sandoz Ag Kristalline Verbindung von 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol und Milchsäure
US9212172B2 (en) 2010-09-14 2015-12-15 Dr. Reddy's Laboratories Limited Preparation of crystalline bazedoxifene and its salts
EP2471770A1 (en) 2010-12-28 2012-07-04 Sandoz Ag Method of preparing polymorphic pure form A of bazedoxifene acetate
CN103864664A (zh) * 2012-12-18 2014-06-18 江苏柯菲平医药有限公司 巴多昔芬乙酸盐新晶型及其制备方法
WO2014186325A1 (en) 2013-05-15 2014-11-20 Indiana University Research And Technology Corporation Processes and intermediates for preparing indole pharmaceuticals
CN103864665B (zh) * 2014-03-04 2016-03-02 苏州特瑞药业有限公司 醋酸巴多昔芬的制备方法
CN104030963A (zh) * 2014-06-30 2014-09-10 四川大学 一种巴多昔芬醋酸盐晶型a的制备方法
CN111004165A (zh) * 2019-12-03 2020-04-14 南京正济医药研究有限公司 一种醋酸巴多昔芬晶型a的制备方法
US11246874B1 (en) 2021-04-20 2022-02-15 Oxygen Biotech LLC Treatment of COVID-19

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780497A (en) 1996-04-19 1998-07-14 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
TW397821B (en) 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
US5998402A (en) 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
SK281737B6 (sk) 1996-04-19 2001-07-10 American Home Products Corporation 2-fenylindolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
US5880137A (en) 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US6005102A (en) 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
PT1025077E (pt) 1997-10-15 2007-05-31 Wyeth Corp Novas ariloxi-alquil-dialquilaminas
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AR029538A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
JP2005535623A (ja) 2002-06-25 2005-11-24 ワイス ホルモン関連症状の治療における、チオ−オキシインドール誘導体の使用
RU2006132180A (ru) 2004-04-07 2008-05-20 Вайет (Us) Кристаллический полиморф базедоксифен ацетата

Similar Documents

Publication Publication Date Title
JP2010506932A5 (cg-RX-API-DMAC7.html)
JP6824409B2 (ja) 六酸化四砒素の結晶多形を含む癌予防または治療用薬学組成物
RU2015103065A (ru) Кристаллическая форма i дималеата ингибитора тирозинкиназы и способ ее получения
KR102707399B1 (ko) Rad1901-2hcl의 다형 형태
CN100546985C (zh) 非布他特微晶及其组合物
JP2020511467A5 (cg-RX-API-DMAC7.html)
JP7473486B2 (ja) Rad1901-2hclの多形形態
RU2009136593A (ru) Кристаллические формы 6-[2-(метилкарбамоил)фенилсульфанил]-3-е-[2-(пиридин-2-ил)этенил]индазола, пригодные для лечения аномального роста клеток у илекопитаюших
RU2010142396A (ru) Кристаллические формы и две сольватные формы солей молочной кислоты 4-амино-5-фтор-3-[5-(4-метилпиперазин-1-ил)-1-н-бензимидазол-2-ил] хинолин-2(1н)она
RU2006132352A (ru) Кристаллическая полиморфная форма базедоксифен ацетата
JP2010514806A5 (cg-RX-API-DMAC7.html)
WO2009103788A9 (en) Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
RU2006132180A (ru) Кристаллический полиморф базедоксифен ацетата
JP7338950B2 (ja) (s)-[3,4-ジフルオロ-2-(2-フルオロ-4-ヨードフェニルアミノ)フェニル][3-ヒドロキシ-3-(ピペリジン-2-イル」)アゼチジン-1-イル]-メタノンの結晶性フマル酸塩
JP2015500331A5 (cg-RX-API-DMAC7.html)
JP2020536893A5 (cg-RX-API-DMAC7.html)
CN104095857B (zh) 闭花木酮Cleistanone的二乙胺衍生物在制备抗肝纤维化药物中的应用
JP2008506690A5 (cg-RX-API-DMAC7.html)
JP2011515421A5 (cg-RX-API-DMAC7.html)
JP2011527330A5 (cg-RX-API-DMAC7.html)
RU2015113277A (ru) Кристаллическтие соединения
CN104140414B (zh) 阿昔替尼晶型的制备方法
CN105439947A (zh) 一种甲苯磺酸索拉非尼新晶型及其制备方法
WO2019195569A1 (en) Solid-state forms of abemaciclib, their use and preparation
WO2014036953A1 (zh) 用于抗肿瘤药物的芳香脲的晶型及其制备方法